Philippe Chanson Selected Research

Acromegaly

1/2022	IGF-I Variability Over Repeated Measures in Patients With Acromegaly Under Long-Acting Somatostatin Receptor Ligands.
1/2022	Pituitary MRI Features in Acromegaly Resulting From Ectopic GHRH Secretion From a Neuroendocrine Tumor: Analysis of 30 Cases.
12/2021	Pegvisomant treatment in acromegaly in clinical practice: Final results of the French ACROSTUDY (312 patients).
11/2021	International Multicenter Validation Study of the SAGIT® Instrument in Acromegaly.
6/2021	Cardiovascular complications of acromegaly.
5/2021	MANAGEMENT OF ENDOCRINE DISEASE: Etiology and outcome of acromegaly in patients with a paradoxical GH response to glucose.
1/2021	Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort study.
1/2021	Correction to: Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort study.
6/2020	Pegvisomant and not somatostatin receptor ligands (SRLs) is first-line medical therapy for acromegaly.
1/2020	Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Acromegaly - Part 1: Diagnostic and Clinical Issues.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philippe Chanson Research Topics

Disease

66	Acromegaly 01/2022 - 01/2005
38	Neoplasms (Cancer) 12/2021 - 07/2004
25	Pituitary Neoplasms (Pituitary Adenoma) 08/2022 - 11/2003
15	Cushing Syndrome 04/2022 - 07/2004
12	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2022 - 12/2003
11	Prolactinoma (Prolactinomas) 08/2022 - 09/2009
11	Adenoma (Adenomas) 05/2021 - 11/2003
9	Hyperprolactinemia 01/2019 - 01/2008
8	Pituitary ACTH Hypersecretion 12/2021 - 04/2012
8	Hypoglycemia (Reactive Hypoglycemia) 01/2021 - 05/2014
7	Hypertension (High Blood Pressure) 12/2018 - 07/2004
5	Insulin Resistance 12/2021 - 05/2004
5	Hyperplasia 12/2021 - 06/2008
5	Carcinogenesis 01/2019 - 10/2006
4	Growth Hormone-Secreting Pituitary Adenoma 11/2021 - 01/2005
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2021 - 01/2010
4	Kallmann Syndrome (Kallmann's Syndrome) 02/2020 - 05/2010
4	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2020 - 09/2011
4	Type 2 Diabetes Mellitus (MODY) 01/2020 - 02/2014
3	Adrenocortical Adenoma (Disease, Conn's) 12/2021 - 06/2007
3	Infertility (Sterility) 05/2021 - 01/2008
3	Headache (Headaches) 05/2021 - 06/2020
3	Major Depressive Disorder (Major Depressive Disorders) 01/2020 - 12/2018
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2019 - 02/2002
3	Primary Hyperparathyroidism 01/2019 - 08/2009
3	Diabetes Mellitus 01/2018 - 07/2011
3	Amenorrhea 11/2017 - 10/2008
3	Adrenocortical Carcinoma 02/2015 - 09/2010
2	Congenital adrenal hyperplasia due to 21 hydroxylase deficiency 03/2022 - 01/2020
2	Hyperparathyroidism 03/2022 - 01/2020
2	Combined Pituitary Hormone Deficiency 06/2021 - 05/2010
2	Chronic Disease (Chronic Diseases) 06/2021 - 02/2005
2	Endocrine System Diseases (Endocrine Diseases) 05/2021 - 06/2015
2	Hyperthyroidism 01/2021 - 05/2017
2	Inflammation (Inflammations) 01/2019 - 01/2015
2	Pheochromocytoma 01/2019 - 11/2003
2	Thyroid Neoplasms (Thyroid Cancer) 01/2019 - 09/2011
2	Overweight 12/2018 - 12/2018
2	Weight Gain 12/2018 - 12/2018
2	Obesity 09/2018 - 02/2010
2	Injection Site Reaction 08/2018 - 02/2017
2	Addison Disease (Addison's Disease) 02/2018 - 12/2017

Drug/Important Bio-Agent (IBA)

33	Insulin-Like Growth Factor I (IGF-1)IBA 01/2022 - 12/2006
25	Growth Hormone (Somatotropin)IBA 11/2021 - 01/2007
16	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2021 - 02/2002
15	ProlactinIBA 08/2022 - 11/2003
12	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2021 - 07/2004
12	Insulin (Novolin)FDA Link 05/2021 - 06/2005
11	Hormones (Hormone)IBA 11/2017 - 12/2003
10	pegvisomant FDA LinkGeneric 12/2021 - 12/2006
10	Dopamine Agonists (Dopamine Agonist)IBA 05/2021 - 01/2008
9	Glucose (Dextrose)FDA LinkGeneric 05/2021 - 05/2009
9	Adrenocorticotropic Hormone (ACTH)FDA Link 10/2020 - 07/2004
8	GonadotropinsIBA 01/2022 - 12/2003
8	Cabergoline FDA LinkGeneric 11/2017 - 01/2008
6	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2022 - 07/2005
6	CalciumIBA 12/2016 - 08/2009
5	GlucocorticoidsIBA 04/2022 - 01/2010
5	LigandsIBA 01/2022 - 07/2005
5	Antidepressive Agents (Antidepressants)IBA 10/2021 - 10/2015
5	Gonadotropin-Releasing Hormone (GnRH)FDA Link 10/2020 - 06/2009
5	SodiumIBA 01/2020 - 07/2008
5	Biomarkers (Surrogate Marker)IBA 09/2019 - 11/2003
5	aryl hydrocarbon receptor-interacting proteinIBA 09/2017 - 07/2007
5	Proteins (Proteins, Gene)FDA Link 09/2017 - 10/2006
5	Vitamin D FDA LinkGeneric 12/2016 - 09/2011
4	gastric inhibitory polypeptide receptorIBA 12/2021 - 01/2017
4	Phosphates (Orthophosphate)IBA 01/2020 - 06/2012
4	Biological ProductsIBA 04/2015 - 07/2014
4	Mitotane (Lysodren)FDA Link 02/2015 - 09/2010
3	Dexamethasone (Maxidex)FDA LinkGeneric 03/2022 - 09/2009
3	SteroidsIBA 02/2021 - 07/2015
3	Furosemide (Lasix)FDA LinkGeneric 01/2020 - 07/2011
3	AndrogensIBA 01/2020 - 06/2007
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 09/2011
3	Temozolomide (Temodar)FDA LinkGeneric 01/2019 - 10/2010
3	2- (4- methyl- 2- thiazolylazo)- 5- diethylaminophenolIBA 12/2018 - 10/2015
3	Metyrapone FDA Link 12/2017 - 09/2011
3	Ketoconazole (Nizoral)FDA LinkGeneric 04/2015 - 09/2011
2	Ga(III)-DOTATOCIBA 05/2022 - 01/2020
2	Vasopressins (Vasopressin)IBA 04/2022 - 12/2011
2	Parathyroid Hormone (Parathormone)IBA 03/2022 - 01/2020
2	Insulin-Like PeptidesIBA 11/2021 - 06/2021
2	LipidsIBA 11/2021 - 06/2021
2	Peptides (Polypeptides)IBA 05/2021 - 02/2014
2	amsonic acid (DAS)IBA 08/2020 - 01/2019
2	AldosteroneIBA 01/2020 - 07/2011
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 02/2018
2	methylamphotericin B (AME)IBA 01/2020 - 01/2020
2	ReninIBA 01/2020 - 07/2011
2	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2018
2	LDL CholesterolIBA 01/2019 - 05/2004
2	KisspeptinsIBA 01/2019 - 01/2016
2	HDL CholesterolIBA 01/2019 - 01/2010
2	3,4-methylenedioxyethamphetamine (MDEA)IBA 12/2018 - 12/2018
2	AntibodiesIBA 02/2018 - 07/2015

Therapy/Procedure

31	Therapeutics 05/2021 - 01/2005
12	Radiotherapy 12/2021 - 07/2005
8	Aftercare (After-Treatment) 01/2018 - 06/2008
3	Adrenalectomy 12/2021 - 06/2007